Tilray Down 90% From Peak — Could US Marijuana Rescheduling Revive the Stock?
Tilray stock has lost approximately 90% of its value from its peak amid a prolonged cannabis sector downturn
Read the full story on market.news
🇺🇸 United States Stocks Regulatory pharma regulatory americas consumer healthcare
What is your take? Drop your thoughts below. 